NCT03384316 Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer Status COMPLETED Phase PHASE1
NCT03370588 The Influence of Perioperative Administration of Dexmedetomidine on Inflammation Response and Postoperative Outcomes in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Cytoreductive Surgery; Double Blind Randomized Controlled Trial Status COMPLETED Phase NA
NCT03361904 Colonoscopic Adenoma and Advanced Neoplasia Detection Rates According to Age Status COMPLETED Phase N/A
NCT03332498 Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers Status COMPLETED Phase PHASE1/PHASE2
NCT03322176 Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing Status UNKNOWN Phase N/A
NCT03306966 Assessing the Safety and Performance of the Endoscopic Linear Cutter Stapler and Reloads (Frankenman) in Colectomy Status WITHDRAWN Phase N/A
NCT03291951 FOcus on Reducing Dose-limiting Toxicities in Colon Cancer With Resistance Exercise Study Status COMPLETED Phase NA
NCT03276091 Colonoscopy Motivation for Patients With Positive Immunochemical Fecal Test Status COMPLETED Phase NA
NCT03200834 Comparison of D2 vs D3 Lymph Node Dissection for Right Colon Cancer (RICON) Status ACTIVE_NOT_RECRUITING Phase NA
NCT03199586 Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies Status COMPLETED Phase PHASE1
NCT03190941 Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients Status RECRUITING Phase PHASE1/PHASE2